Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity
Abstract
Although the pathogenesis of Parkinson's disease (PD) remains unknown, it appears that microglial activation is associated with enhanced neurodegeneration in animal models of PD as well as in PD patients. Experimentally, C57BL/6 and SWR/J mice demonstrate striking differences in the extent of dopaminergic (DAergic) neurodegeneration induced by a parkinsonian toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The purpose of this study was to determine whether differences in microglial activation between these two strains of mice could provide insight into the variability seen in toxicant induced neuronal death, and subsequently to use a high-throughput proteomic method, combining stable isotope labeling with amino acids in cell culture (SILAC) with liquid chromatography and tandem mass spectrometry, to compare the microglial proteomes of C57BL/6 and SWR/J mice after stimulation with a classical microglial activator, lipopolysaccharide (LPS). We found that DAergic neurotoxicity induced by LPS in a primary neuron-microglia coculture was twofold greater with microglia isolated from the brains of C57BL/6 mice compared with that of SWR/J mice. Upon proteomic analysis we found that, out of over 1,000 proteins identified and quantified, 400 displayed a significant difference in their relative abundance between these two murine strains. Several proteins, which had relatively higher levels in C57BL/6 mice, have previously been implicated in LPS-mediated microglial activation, including those involved in the COX-2 pathway and in prostaglandin E-2 (PGE(2)) production. To validate our proteomic results we confirmed the increased expression level of iNOS in C57BL/6 vs. SWR/J microglia with semiquantitative Western blot. Further analysis of our proteomic discovery data will likely reveal numerous novel proteins involved in inflammation-mediated neurotoxicity in PD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of NF-kB can increase the release of proinflammatory cytokines TNF-α and IL-1β by microglial cells.
“The activation of this factor could increase the release of proinflammatory cytokines such TNF-α and interleukin 1β by microglial cells (Mogi et al., 1996; McLaughlin et al., 2006).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as McLaughlin et al., 2006
Cites
Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., & Mann, M. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200025-mcp200 · Cited by 5,574 · see citing works
A statistical model for identifying proteins by tandem mass spectrometry.
Nesvizhskii, A., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,902 · see citing works
Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400129-mcp200 · Cited by 4,401 · see citing works
Correlation between Protein and mRNA Abundance in Yeast
Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1720 · Cited by 3,819 · see citing works
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works
Direct analysis of protein complexes using mass spectrometry
Link, A. J., Eng, J. K., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., & Yates, J. R. (1999) · Nature Biotechnology · doi:10.1038/10890 · Cited by 2,218 · see citing works
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,394 · see citing works
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works
Self-citationWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095 · see citing works
Schwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 741 · see citing works
Gao, H., Jiang, J., Wilson, B. C., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 690 · see citing works
Griffin, T. J., Gygi, S. P., Ideker, T. E., Rist, B., Eng, J. K., Hood, L., & Aebersold, R. H. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200001-mcp200 · Cited by 663 · see citing works
Protein Sequencing and Identification Using Tandem Mass Spectrometry
Kinter, M. T., & Sherman, N. E. (2000) · Wiley eBooks · doi:10.1002/0471721980 · Cited by 657 · see citing works
Qin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574 · see citing works
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Alam, M., & Schmidt, W. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00180-8 · Cited by 475 · see citing works
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H., Hong, J., Zhang, W., & Liu, B. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439 · see citing works
Cicchetti, F., Brownell, A., Williams, K. S., Chen, Y. I., Livni, E., & Ole Isacson, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406 · see citing works
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
Ferfoglia, R. I., Mohapel, P., Brundin, P., & Paul, G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.023 · Cited by 380 · see citing works
Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · see citing works
Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation
Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363 · see citing works
Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?
Hirsch, É. C., Hunot, S., Damier, P., & Faucheux, B. A. (1998) · Annals of Neurology · doi:10.1002/ana.410440717 · Cited by 334 · see citing works
Liu, B., Gao, H., & Hong, J. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6361 · Cited by 285 · see citing works
Kohutnicka, M., Lewandowska, E., Kurkowska‐Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283 · see citing works
Gao, H., Hong, J., Zhang, W., & Liu, B. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251 · see citing works
Molecular Pathogenesis of Parkinson Disease
Eriksen, J. L., Wszołek, Z. K., & Petrucelli, L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.353 · Cited by 248 · see citing works
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 239 · see citing works
Chapter 36: Astrocytes and Parkinson's disease
Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. A. D., & Langston, J. W. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230 · see citing works
Everley, P. A., Krijgsveld, J., Zetter, B. R., & Gygi, S. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400021-mcp200 · Cited by 226 · see citing works
Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease
Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E. R., Kaye, J. A., Zhou, Y. F., Pan, C., Yi, E. C., Eng, J. K., Wang, Q., et al. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7205 · Cited by 174 · see citing works
Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics
Zhou, Y. F., Gu, G., Goodlett, D. R., Zhang, T., Pan, C., Montine, T. J., Montine, K. S., Aebersold, R. H., & Zhang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405456200 · Cited by 173 · see citing works
Carvey, P. M. (2003) · Frontiers in bioscience · doi:10.2741/1158 · Cited by 161 · see citing works
Ibarrola, N., Kalume, D. E., Grønborg, M., Iwahori, A., & Pandey, A. (2003) · Analytical Chemistry · doi:10.1021/ac034931f · Cited by 161 · see citing works
Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
McGeer, P. L., & McGeer, E. G. (1998) · PubMed · Cited by 157 · see citing works
Persson, M., Brantefjord, M., Hansson, E., & Rönnbäck, L. (2005) · Glia · doi:10.1002/glia.20191 · Cited by 154 · see citing works
Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease
Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151 · see citing works
Gao, H., Liu, B., Zhang, W., & Hong, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0203fje · Cited by 149 · see citing works
Kim, E. J., Kwon, K. J., Park, J.-Y., Lee, S., Moon, C., & Baik, E. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02480-0 · Cited by 137 · see citing works
Hamre, K., Tharp, R., Poon, K. K.-Y., Xiong, X., & Smeyne, R. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01273-1 · Cited by 133 · see citing works
Levi, G., Minghetti, L., & Aloisi, F. (1998) · Biochimie · doi:10.1016/s0300-9084(00)88886-0 · Cited by 133 · see citing works
Speciale, S. G. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00222-2 · Cited by 132 · see citing works
Toll-Like Receptors and Inflammation in the CNS
Lee, B. S. P. S. J., & Lee, B. S. P. S. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344698 · Cited by 127 · see citing works
Molecular Signals for Glial Activation: Pro- and Anti-Inflammatory Cytokines in the Injured Brain
Raivich, G., Jones, L. L., Werner, A., Blüthmann, H., Doetschmann, T., & Kreutzberg, G. W. (1999) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-6391-7_4 · Cited by 123 · see citing works
Arai, H., Furuya, T., Yasuda, T., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407328200 · Cited by 122 · see citing works
Neurodegeneration or Neuroprotection: The Pivotal Role of Astrocytes
Heales, S., Lam, A., Duncan, A. J., & Land, J. M. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014822.69384.0f · Cited by 104 · see citing works
Fiebich, B. L., Lieb, K., Engels, S., & Heinrich, M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00279-5 · Cited by 96 · see citing works
McNaught, K. S. P., & Jenner, P. G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00415-9 · Cited by 86 · see citing works
Amanchy, R., Kalume, D. E., & Pandey, A. (2005) · Science s STKE · doi:10.1126/stke.2672005pl2 · Cited by 86 · see citing works
Ikeda‐Matsuo, Y., Ikegaya, Y., Matsuki, N., Uematsu, S., Akira, S., & Sasaki, Y. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03302.x · Cited by 86 · see citing works
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
Kegeles, L. S., Zea‐Ponce, Y., Abi‐Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Heertum, R. L. V., Mann, J. J., & Laruelle, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4 · Cited by 80 · see citing works
Microglial Activation Induced by Neurodegeneration
Zhou, Y. F., Wang, Y., Kovacs, M., Jin, J., & Zhang, J. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500114-mcp200 · Cited by 79 · see citing works
Glial Cell Reactions in Neurodegenerative Diseases Pathophysiology and Therapeutic Interventions
McGeer, P. L., & McGeer, E. G. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199803001-00001 · Cited by 75 · see citing works
Romijn, E. P., Christis, C., Wieffer, M., Gouw, J. W., Fullaondo, A., van der Sluijs, P., Braakman, I., & Heck, A. J. R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500123-mcp200 · Cited by 71 · see citing works
Ma, M., Wei, P. Y., Wei, T., Ransohoff, R. M., & Jakeman, L. B. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20149 · Cited by 69 · see citing works
Glia cell number modulates sensitivity to MPTP in mice
Smeyne, M., Jiao, Y., Shepherd, K. R., & Smeyne, R. J. (2005) · Glia · doi:10.1002/glia.20233 · Cited by 61 · see citing works
Jeohn, G., Cooper, C. L., Wilson, B. C., Chang, R. C., Jang, K., Kim, H.-C., Liu, B., & Hong, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04078.x · Cited by 60 · see citing works
Strain‐dependent susceptibility to MPTP and MPP‐induced Parkinsonism is determined by glia
Smeyne, M., Goloubeva, O. G., & Smeyne, R. J. (2001) · Glia · doi:10.1002/glia.1042.abs · Cited by 52 · see citing works
Shie, F., Neely, M. D., Maezawa, I., Wu, H. H., Olson, S. J., Jürgens, G., Montine, K. S., & Montine, T. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63205-1 · Cited by 49 · see citing works
Sundström, E., & Samuelsson, E. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00051.x · Cited by 39 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A., & Schuman, E. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601637103 · Cited by 874 · see citing works
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466 · see citing works
Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease
Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P. S., Cerny, R. L., Gelman, B. B., Thomas, M. P., Mosley, R. L., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 244 · see citing works
Therapeutic approaches to inflammation in neurodegenerative disease
Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 186 · see citing works
Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1
Jin, J., Li, G. J., Davis, J., Zhu, D. C., Wang, Y., Pan, C., & Zhang, J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600182-mcp200 · Cited by 179 · see citing works
Zhang, W., Dallas, S., Zhang, D., Guo, J., Pang, H., Wilson, B. C., Miller, D. S., Chen, B., Zhang, W., McGeer, P. L., et al. (2007) · Glia · doi:10.1002/glia.20532 · Cited by 161 · see citing works
Evidence of Inflammatory System Involvement in Parkinson’s Disease
Chao, Y., Wong, S. C., & Tan, E. K. (2014) · BioMed Research International · doi:10.1155/2014/308654 · Cited by 150 · see citing works
Jin, J., Shie, F., Liu, J., Wang, Y., Davis, J., Schantz, A. M., Montine, K. S., Montine, T. J., & Zhang, J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-2 · Cited by 112 · see citing works
Proteomics in human Parkinson's disease research
Licker, V., Kövari, E., Hochstrasser, D. F., & Burkhard, P. R. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.07.007 · Cited by 103 · see citing works
Inflammatory response in Parkinson’s disease (Review)
Yan, J., Fu, Q., Cheng, L.-N., ZHAI, M., Wu, W., Huang, L., & Du, G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2563 · Cited by 101 · see citing works
The Role of Anti-Inflammatory Agents in Parkinson???s Disease
McGeer, E. G., & McGeer, P. L. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00001 · Cited by 95 · see citing works
Olson, K. E., Kosloski, L. M., Anderson, K. M., Diggs, B. J., Clark, B. E., Gledhill, J. M., Shandler, S. J., Mosley, R. L., & Gendelman, H. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2131-15.2015 · Cited by 89 · see citing works
Amino acid-coded tagging approaches in quantitative proteomics
Chen, X., Sun, L., Yu, Y., Xue, Y., & Yang, P. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.1.25 · Cited by 87 · see citing works
Proteomic Studies of Nitrated Alpha-Synuclein Microglia Regulation by CD4+CD25+ T Cells
Reynolds, A. D., Stone, D. K., Mosley, R. L., & Gendelman, H. E. (2009) · Journal of Proteome Research · doi:10.1021/pr9001614 · Cited by 83 · see citing works
Proteomics in animal models of Alzheimer's and Parkinson's diseases
Robinson, R. A. S., Owen, J. B., & Butterfield, D. A. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.003 · Cited by 81 · see citing works
Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water
Krishna, S., Dodd, C. A., Hekmatyar, S. K., & Filipov, N. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1088-3 · Cited by 80 · see citing works
Aging Neural Progenitor Cells Have Decreased Mitochondrial Content and Lower Oxidative Metabolism
Stoll, E. A., Cheung, W., Mikheev, A. M., Sweet, I. R., Bielas, J. H., Zhang, J., Rostomily, R., & Horner, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252171 · Cited by 74 · see citing works
Pattarini, R., Smeyne, R. J., & Morgan, J. I. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.030 · Cited by 70 · see citing works
Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
Chiurchiù, V., Tiberi, M., Matteocci, A., Fazio, F., Siffeti, H., Saracini, S., Mercuri, N. B., & Sancesario, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116235 · Cited by 68 · see citing works
Chien, C.-H., Lee, M., Liou, H., Liou, H., & Fu, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151569 · Cited by 63 · see citing works
Neurotoxicity of microglial cathepsin D revealed by secretome analysis
Kim, S., Ock, J., Kim, A. K., Lee, H., Cho, J., Kim, D. R., Park, J., & Suk, K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04995.x · Cited by 63 · see citing works
Nikodémová, M., & Watters, J. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.006 · Cited by 62 · see citing works
Sita, G., Hrelia, P., Tarozzi, A., & Morroni, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091454 · Cited by 62 · see citing works
Activated Immune Cells in Parkinson's Disease
Cao, J., Li, K., & Shen, Y. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9280-9 · Cited by 44 · see citing works
Liu, J., Hong, Z., Ding, J., Liu, J., Zhang, J., & Chen, S. (2008) · Journal of Proteome Research · doi:10.1021/pr7007779 · Cited by 41 · see citing works
Klegeris, A., Li, J., Bammler, T. K., Jin, J., Zhu, D. C., Kashima, D. T., Pan, S., Hashioka, S., Maguire, J. A., McGeer, P. L., et al. (2008) · Glia · doi:10.1002/glia.20645 · Cited by 39 · see citing works
Yasuda, Y. U., Shinagawa, R., Yamada, M., Mori, T. A., Tateishi, N., & Fujita, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.054 · Cited by 35 · see citing works
Dou, F., Chu, X., Zhang, B., Liang, L., Lü, G., Ding, J., & Chen, S. (2018) · Molecular Brain · doi:10.1186/s13041-018-0418-z · Cited by 34 · see citing works
Proteomics in Parkinson’s disease: current trends, translational snags and future possibilities
Srivastava, G., Singh, K., Tiwari, M. N., & Singh, M. P. (2010) · Expert Review of Proteomics · doi:10.1586/epr.09.91 · Cited by 31 · see citing works
Glia-based biomarkers and their functional role in the CNS
Jha, M. K., & Suk, K. (2013) · Expert Review of Proteomics · doi:10.1586/epr.12.70 · Cited by 28 · see citing works
Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders
Hemsley, K. M., & Hopwood, J. J. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9078-6 · Cited by 27 · see citing works
Park, B., Yang, J.-Y., Yun, N., Choe, K., Jin, B. K., & Oh, Y. J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.005 · Cited by 25 · see citing works
A proteome map of primary cultured rat Schwann cells
Shen, M., Ji, Y., Zhang, S., Shi, H., Chen, G., Gu, X., & Ding, F. (2012) · Proteome Science · doi:10.1186/1477-5956-10-20 · Cited by 24 · see citing works
Emergent Properties of Microglia
Svahn, A. J., Becker, T. S., & Graeber, M. B. (2014) · Brain Pathology · doi:10.1111/bpa.12195 · Cited by 23 · see citing works
Clinical proteomics in neurodegenerative diseases
Zhou, J., Hanfelt, J., & Peng, J. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700378 · Cited by 23 · see citing works
Özsoy, Ö., Tanrιöver, G., Derin, N., Uysal, N., Demır, N., Gemici, B., Kencebay, C., Yargıçoğlu, P., Ağar, A., & Aslan, M. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9238-y · Cited by 22 · see citing works
The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
Huang, B., Zhenxin, Y., Chen, S., Tan, Z., Zong, Z., Zhang, H., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1315248 · Cited by 19 · see citing works
Hong, Z., Zhang, Q.-Y., Liu, J., Wang, Z., Zhang, Y., Xiao, Q., Lü, J., Zhou, H.-Y., & Chen, S.-D. (2009) · Journal of Proteome Research · doi:10.1021/pr801052v · Cited by 19 · see citing works
Li, Y., Stewart, T., Shi, M. Y., Pottiez, G., Dator, R., Wu, R., Aro, P., Schuster, R. J., Ginghină, C., Pan, C., et al. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700045 · Cited by 19 · see citing works
Oxidative stress in a rat model of chronic gliosis
Bates, K. A., Martins, R. N., & Harvey, A. R. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.003 · Cited by 17 · see citing works
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18 · see citing works
Selective Vulnerability of Neurons in Primary Cultures and in Neurodegenerative Diseases
Chen, J., & Herrup, K. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.317 · Cited by 15 · see citing works
Acar, N., Parlak, H., Özkan, A., Soylu, H., Avcı, S., Üstünel, İ., Izgut-Uysal, V. N., & Ağar, A. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.12.002 · Cited by 13 · see citing works
Jeon, S.-J., Kwon, K.-J., Shin, S. M., Lee, S.-H., Rhee, S. Y., Han, S., Lee, J., Kim, H.-Y., Cheong, J.-H., Ryu, J.-H., et al. (2009) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2009.17.1.70 · Cited by 13 · see citing works
Neuroproteomics and the Detection of Regulatory Phosphosites
Tweedie‐Cullen, R. Y., Wollscheid, B., Livingstone-Zatchej, M., & Mansuy, I. M. (2007) · Current Proteomics · doi:10.2174/157016407783221240 · Cited by 10 · see citing works
Shin, D.-I., & Oh, Y. J. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.65 · Cited by 9 · see citing works
Stojić-Vukanić, Z., Pilipović, I., Djikić, J., Vujnović, I., Nacka-Aleksić, M., Bufan, B., Arsenović-Ranin, N., Kosec, D., & Leposavić, G. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.11.002 · Cited by 7 · see citing works
Proteomics in the study of hippocampal plasticity
Cobb, S., & Pitt, A. R. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.3.393 · Cited by 8 · see citing works
Characterization of a SILAC method for proteomic analysis of primary rat microglia
Zhang, P., Culver‐Cochran, A. E., Stevens, S. M., & Liu, B. (2016) · PROTEOMICS · doi:10.1002/pmic.201500390 · Cited by 7 · see citing works
Strain-dependent inflammatory responsiveness of rat microglial cells
Wei, R., & Lin, C.-M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.007 · Cited by 7 · see citing works
In Vitro Systems in Neurotoxicological Studies
Audesirk, G. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01325-7 · Cited by 2 · see citing works
Proteomic Approaches to Axon Injury – Postgenomic Approaches to a Posttranscriptional Process
Michaelevski, I., & Fainzilber, M. (2008) · Wiley eBooks · doi:10.1002/9783527622467.ch7
Nobarı, H., Parnian-Khajehdizaj, N., & Fleming, A. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106980
- Authors
- McLaughlin, P., Zhou, Y., Ma, T., Liu, J., Zhang, W., Hong, J., Kovacs, M., & Zhang, J.
- Affiliations
- University of Washington (US)
- National Institutes of Health (US)
- Corresponding author
- Zhang, Jing
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2006-01-17
- Volume
- 53
- Issue
- 6
- Pages
- 567-582
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2091691893
- Cited by
- 55
- References
- 59
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 1
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Glia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (ES05842)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- microglial activation, Parkinson's disease, dopaminergic neurotoxicity, MPTP, lipopolysaccharide, strain differences, C57BL/6 mice, SWR/J mice, prostaglandin E2, inducible nitric oxide synthase, neuroinflammation, neurodegeneration
- MeSH terms
- Animals, Cells, Cultured, Dopamine, Encephalitis, Gliosis, Lipopolysaccharides, Mice, Inbred C57BL, Nerve Degeneration, Nerve Tissue Proteins, Neurotoxins, Parkinson Disease, Species Specificity, Dinoprostone, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Rats, Sprague-Dawley, Microglia, Inflammation Mediators, Coculture Techniques, Proteomics, Mice, Rats, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
